SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001262463-21-000035
Filing Date
2021-02-16
Accepted
2021-02-16 08:47:47
Documents
43
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gwhp12312020q.htm 10-Q 273803
2 EXHIBIT 10.4 ex104.htm EX-10 57922
3 EXHIBIT 31.1 ex311.htm EX-31 9381
4 EXHIBIT 32.1 ex321.htm EX-32 4032
5 GRAPHIC logo.gif GRAPHIC 9166
  Complete submission text file 0001262463-21-000035.txt   1932137

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE gwhp-20201231.xml EX-101.INS 215308
7 XBRL SCHEMA FILE gwhp-20201231.xsd EX-101.SCH 25289
8 XBRL CALCULATION FILE gwhp-20201231_cal.xml EX-101.CAL 34982
9 XBRL DEFINITION FILE gwhp-20201231_def.xml EX-101.DEF 92509
10 XBRL LABEL FILE gwhp-20201231_lab.xml EX-101.LAB 179087
11 XBRL PRESENTATION FILE gwhp-20201231_pre.xml EX-101.PRE 160371
Mailing Address 2227 AVENIDA OLIVA SAN CLEMENTE CA 92673
Business Address 2227 AVENIDA OLIVA SAN CLEMENTE CA 92673 (714) 392-4112
Global Wholehealth Partners Corp (Filer) CIK: 0001598308 (see all company filings)

IRS No.: 462316220 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-56035 | Film No.: 21632957
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences